Publicaciones en colaboración con investigadores/as de Instituto IMDEA Alimentación (16)

2023

  1. Clinical features and lipid metabolism genes as potential biomarkers in advanced lung cancer

    BMC Cancer, Vol. 23, Núm. 1

  2. Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review

    Current Oncology, Vol. 30, Núm. 10, pp. 9335-9345

  3. M-Health in lung cancer: A literature review

    SAGE Open Medicine, Vol. 11

  4. The mHealth ALIBIRD Platform: Supporting Cancer Patient Treatment and Follow-up

    Proceedings - IEEE Symposium on Computer-Based Medical Systems

2022

  1. Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic

    Frontiers in Oncology, Vol. 12

2021

  1. Article a multicenter analysis of the outcome of cancer patients with neutropenia and covid-19 optionally treated with granulocyte-colony stimulating factor (G-csf): A comparative analysis

    Cancers, Vol. 13, Núm. 16

  2. Immune checkpoint inhibitors in endometrial cancer

    Critical Reviews in Oncology/Hematology, Vol. 161

  3. Metabolic health together with a lipid genetic risk score predicts survival of small cell lung cancer patients

    Cancers, Vol. 13, Núm. 5, pp. 1-8

  4. Ras mutational status in advanced colorectal adenocarcinoma treated with anti-angiogenics: Preliminary experience with liquid biopsy

    In Vivo, Vol. 35, Núm. 5, pp. 2841-2844

2020

  1. Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer

    Cancer Biology and Medicine, Vol. 17, Núm. 2, pp. 444-457

  2. Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer

    Molecular Oncology, Vol. 14, Núm. 12, pp. 3135-3152

2019

  1. Erratum to “Lipid metabolism and lung cancer” [Crit. Rev. Oncol. Hematol. 112, April (2017), 31–40](S1040842817300513)(10.1016/j.critrevonc.2017.02.001)

    Critical Reviews in Oncology/Hematology

  2. Tolerability and safety of a nutritional supplement with potential as adjuvant in colorectal cancer therapy: A randomized trial in healthy volunteers

    Nutrients, Vol. 11, Núm. 9

2018

  1. Antinuclear antibodies and cancer: A literature review

    Critical Reviews in Oncology/Hematology, Vol. 127, pp. 42-49

2017

  1. Lipid metabolism and lung cancer

    Critical Reviews in Oncology/Hematology, Vol. 112, pp. 31-40

2014

  1. Application of novel genotyping microarray technologies in cancer research

    Comprehensive Analytical Chemistry (Elsevier B.V.), pp. 47-73